ACADIA PHARMACEUTICALS INC ACAD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-05-27
ACADIA PHARMACEUTICALS INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 12,062,213 | $196.0M |
| Point72 Asset Management, L.P. | 2,605,316 | $58.0M |
| RENAISSANCE TECHNOLOGIES LLC | 1,724,196 | $38.4M |
| TWO SIGMA INVESTMENTS, LP | 775,121 | $17.3M |
| D. E. Shaw & Co., Inc. | 729,836 | $16.2M |
| MILLENNIUM MANAGEMENT LLC | 705,461 | $15.7M |
| CITADEL ADVISORS LLC | 658,660 | $14.7M |
| AQR CAPITAL MANAGEMENT LLC | 527,913 | $11.8M |
Source: SEC EDGAR filings · CIK 0001070494 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.